期刊文献+

STAT5在造血调控及相关血液疾病发生中的作用 被引量:1

Roles of STAT5 in Hematopoietic Regulation and Blood Diseases——Review
下载PDF
导出
摘要 信号转导与转录活化因子5(STAT5)是一种广泛存在于多种组织细胞胞浆内的转录因子,在被激活后能够进入细胞核与特异性DNA序列结合,从而发挥转录调控作用。STAT5有STAT5A和STAT5B两种异构体,二者具有96%的同源性,但其生理功能并不完全相同。研究显示,STAT5能够调节造血细胞的生存、增殖、分化和凋亡,它的过度激活与多种血液系统恶性疾病的病理发生过程密切相关,所以STAT5在临床上可能成为一个新的治疗靶点。本文就该分子在造血调控及相关血液疾病中发挥的作用加以阐述。 Signal transducer and activator of transcription 5 (STAT5) is an important transcription factor existing in the cytoplasm of various types of cells. Once activated, STAT5 dimers translocate into nucleus and bind to the corresponding DNA sequence to regulate the transcription of its target genes. There are two isoforms of STATS: STAT5A and STAT5B with 96% sequence homology and are encoded by two closely related but different genes. Studies have shown that STAT5 can regulate the survival, proliferation, differentiation and death of hematopoietic cells. Furthermore, elevated activation of STAT5 was found in many malignant hematologic diseases and therefore raised the possibility that STAT5 may be used as a new therapeutic target for blood related diseases. This review discusses the regulatory role of STAT5 in hematopoietic cells and its effect on the occurrence and development of blood diseases.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2012年第6期1496-1500,共5页 Journal of Experimental Hematology
基金 科技部重大国际合作:(编号2010DFB30270) 国家自然科学基金(编号81090411,30825017,90913018,81130074,81070390,30971110)
关键词 STAT5 造血调控 造血干细胞 恶性血液病 STAT5 hematopoietic regulation hematopoietic stem cell malignant hematologic diseases
  • 相关文献

参考文献39

  • 1Tweardy D, Chang JC. STAT5 : from breast development to cancerprognosis, prediction, and progression. J Clin Oncol, 2011 ; 29 ( 18 ) :2443 - 2444.
  • 2Heltemes-Harris LM, Willette MJ, Vang KB, et al. The role of STAT5 in the development, function, and transformation of B and T lymphocytes. Ann NY Acad Sci, 2011 ;1217:18 -31.
  • 3Ambrosio R, Fimiani G, Monfregola J, et al. The structure of human STAT5A and B genes reveals two regions of nearly identical sequence and an alternative tissue specific STAT5B promoter. Gene, 2002;285(1 -2) :311 -318.
  • 4Nosaka T, Kawashirna T, Misawa K, et al. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hemato- poietic cells. EMBO J, 1999 ; 18 ( 17 ) :4754 - 4765.
  • 5Li G, Wang Z, Zhang Y, et al. STAT5 requires the N-domain to maintain hematopoietic stem cell repopulating function and appropriate lymphoid-myeloid lineage output. Exp Hematol, 2007 ; 35 ( 11 ) : 1684 - 1694.
  • 6Moore MA, Dorn DC, Schuringa JJ, et al. Constitutive activation of Fit3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells. Exp Hematol, 2007 ; 35 (4 Suppl 1 ) : 105 - 116.
  • 7Han L, Wierenga AT, Rozenveld-Geugien M, et al. Single-cell STAT5 signal transduction profiling in normal and leukemic stem and progenitor cell populations reveals highly distinct cytokine responses. PIoS One, 2009 ;4 ( 11 ) : e7989.
  • 8Nelson EA, Walker SR, Weisberg E, et al. The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors. Blood, 2011 ;117 (12) :3421 -3429.
  • 9Kato Y, lwama A, Tadokoro Y, et al. Selective activation of STAT5 unveils its role in stem cell self-renewal in normal and leukemic hematopoiesis. J Exp Med, 2005 ;202(1 ) :169 - 179.
  • 10Schepers H, van Gosliga D, Wierenga AT, et al. STAT5 is required for long-term maintenance of normal and leukemic human stern/progenitor cells. Blood, 2007 ; 110 ( 8 ) :2880 - 2888.

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部